Provided by Tiger Trade Technology Pte. Ltd.

Lineage

38.79
-0.4600-1.17%
Post-market: 39.470.6800+1.75%18:20 EDT
Volume:695.15K
Turnover:27.23M
Market Cap:8.81B
PE:-53.87
High:39.96
Open:39.35
Low:38.69
Close:39.25
52wk High:45.75
52wk Low:31.33
Shares:227.08M
Float Shares:57.19M
Volume Ratio:0.92
T/O Rate:1.22%
Dividend:2.12
Dividend Rate:5.47%
EPS(TTM):-0.7200
EPS(LYR):-0.4300
ROE:-2.04%
ROA:0.75%
PB:1.12
PE(LYR):-90.21

Loading ...

Adam Kramer Maintains Hold on Lineage Amid Transitional 2026, Soft Same-Store Trends, and Uncertain Demand Recovery

TIPRANKS
·
May 06

Lineage Q1 Adjusted FFO Falls, Revenue Rises; Reiterates Full-Year AFFO Outlook

MT Newswires Live
·
May 06

GUIDANCE: (LINE) Lineage Expects 2026 Adjusted FFO per Share Range $2.75 to $3.00, vs. FactSet Est of $2.88

MT Newswires Live
·
May 06

Lineage Q1 revenue misses estimates, adjusted EBITDA beats

Reuters
·
May 06

Earnings Flash (LINE) Lineage Posts Q1 AFFO $0.78 a Share, vs. FactSet Est of $0.70

MT Newswires Live
·
May 06

Lineage Q1 EPS $(0.18) Misses $(0.14) Estimate, Sales $1.297B Miss $1.322B Estimate

Benzinga Earnings
·
May 06

Lineage Inc - Sees FY2026 Adj Ebitda $1.25-$1.30 Bln; Affo per Share $2.75-$3.00

THOMSON REUTERS
·
May 06

Lineage Inc: Supply Chain Conditions Remain Challenging Due to Tariff Uncertainty and Geopolitical Disruptions

THOMSON REUTERS
·
May 06

Lineage Inc Q1 Adjusted Ffo per Share USD 0.78

THOMSON REUTERS
·
May 06

Lineage Inc Q1 Pretax Profit USD -47 Million

THOMSON REUTERS
·
May 06

Lineage, Inc. Reports First-Quarter 2026 Financial Results

THOMSON REUTERS
·
May 06

Top News Today: Stocks Rise, Oil Falls, as War Restart Fears Subside

Dow Jones
·
May 06

Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
May 04

Lineage Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
May 04

Earning Preview: Lineage this quarter’s revenue is expected to decrease by 1.25%, and institutional views are leaning bullish

Earnings Agent
·
Apr 29

Lineage Cell Therapeutics Initiated at Buy by Canaccord Genuity

Dow Jones
·
Apr 29

Canaccord Genuity Initiates Coverage on Lineage Cell Therapeutics With Buy Rating, $9 PT

MT Newswires Live
·
Apr 28

Lineage Cut to Underweight From Equal-Weight by Barclays

Dow Jones
·
Apr 27

Lineage Inc. : Barclays Cuts to Underweight From Equal-Weight

THOMSON REUTERS
·
Apr 27

Lineage downgraded to Underweight from Equal Weight at Barclays

TIPRANKS
·
Apr 27